Alzheimer's

Alzheimer’s disease is a relentless and fatal illness, creating a profound health crisis for patients, families, and societies worldwide. Without meaningful progress, the societal costs will be staggering.

Global thought leaders have set an ambitious goal: to develop a treatment that can slow the progression of Alzheimer’s by 2025. While late-stage clinical successes have been elusive over the past decade, scientific understanding of the disease has advanced dramatically, particularly in the areas of early diagnosis and disease progression. This episode explores the evolving science of Alzheimer’s, the surge in drug development targeting patients in the earliest stages, and the promise that earlier intervention could deliver better outcomes for patients.